Financials in USD. Standardized financial statements.
A compact view of how BioPower Operations Corporation turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $571,700 | $175,000 | $0 | $0 | $13,420 | $111,401 | $258,734 | $0 | $0 |
| Revenue Growth? | +226.7% | 0.0% | 0.0% | -100.0% | -88.0% | -56.9% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $0 | $0 | $0 | $0 | $24,984 | $12,341 | $5,552 | $10,552 | $0 |
| Gross Profit? | $571,700 | $175,000 | $0 | $0 | -$11,564 | $99,060 | $253,182 | -$10,552 | $0 |
| Gross Margin? | +100.0% | +100.0% | 0.0% | 0.0% | -86.2% | +88.9% | +97.9% | 0.0% | 0.0% |
| Operating Expenses? | $1.16M | $461,263 | -$129,745 | -$129,745 | $1.97M | $1.10M | $1.30M | $984,870 | $964,605 |
| Operating Income? | -$591,784 | -$286,263 | -$129,745 | -$129,745 | -$1.96M | -$2.02M | -$1.30M | -$984,870 | -$964,605 |
| EBITDA? | $65,972 | $0 | $0 | -$129,745 | -$1.96M | -$1.09M | -$1.30M | -$974,318 | -$956,953 |
| Income Before Tax | -$792,534 | -$441,324 | -$129,745 | -$129,745 | -$2.21M | -$2.09M | -$1.34M | -$1.27M | -$968,655 |
| Income Tax Expense | $0 | $0 | $0 | $0 | -$14,539 | $106,285 | $32,893 | $0 | $0 |
| Net Income? | -$792,534 | -$441,324 | -$129,745 | -$129,745 | -$2.21M | -$2.09M | -$1.34M | -$1.27M | -$968,655 |
| EPS? | $-0.02 | $-0.01 | $-0.00 | $-0.00 | $-0.05 | $-0.07 | $-0.06 | $-0.07 | $-0.06 |
| Diluted EPS? | $-0.02 | $-0.01 | $-0.00 | $-0.00 | $-0.05 | $-0.07 | $-0.06 | $-0.07 | $-0.06 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality